Literature DB >> 10094098

New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.

A M De Marzo1, D S Coffey, W G Nelson.   

Abstract

Of the hundreds of species of mammals, all of which have prostate glands, only humans and dogs are known to suffer from benign prostatic hyperplasia (BPH) and prostate carcinoma. In humans, prostate carcinoma is common, yet carcinomas of other sex accessory tissues are rare. In addition, different anatomic regions within the prostate gland have very different rates of BPH and carcinoma. In this article, we explore ideas and potential mechanisms relating to these paradoxical findings that may help explain the species, organ, and zone specificity of BPH and prostate cancer. We present an evolutionary argument that attempts to relate a high-fat diet, with its potential for generating oxidative DNA damage, to the species selectivity of prostate cancer. In addition, we outline an argument based on our preliminary studies indicating that chronic inflammation and the associated increase in cell turnover in the setting of increased oxidative stress may help to account for the organ selectivity of genitourinary carcinomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094098     DOI: 10.1016/s0090-4295(98)00536-6

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  25 in total

1.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.

Authors:  A M De Marzo; V L Marchi; J I Epstein; W G Nelson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 2.  Targeting phenotypic heterogeneity in benign prostatic hyperplasia.

Authors:  Douglas W Strand; Daniel N Costa; Franto Francis; William A Ricke; Claus G Roehrborn
Journal:  Differentiation       Date:  2017-08-04       Impact factor: 3.880

Review 3.  Human prostate cancer heterotransplants: a review on this experimental model.

Authors:  Lluis A Lopez-Barcons
Journal:  Asian J Androl       Date:  2010-04-05       Impact factor: 3.285

4.  Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays.

Authors:  Kulkarni Prakash; Gregorio Pirozzi; Michael Elashoff; William Munger; Iwao Waga; Rajiv Dhir; Yoshiyuki Kakehi; Robert H Getzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

5.  Multi-parametric MR imaging of transition zone prostate cancer: Imaging features, detection and staging.

Authors:  Arda Kayhan; Xiaobing Fan; Jacob Oommen; Aytekin Oto
Journal:  World J Radiol       Date:  2010-05-28

6.  Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells.

Authors:  Wen-Yang Hu; Guang-Bin Shi; Hung-Ming Lam; Dan-Ping Hu; Shuk-Mei Ho; Ikenna C Madueke; Andre Kajdacsy-Balla; Gail S Prins
Journal:  Endocrinology       Date:  2011-03-22       Impact factor: 4.736

7.  The effect of prostate cancer and antiandrogenic therapy on lipid peroxidation and antioxidant systems.

Authors:  Alkan Hacer Iynem; Ayşe Zeynep Alademir; Can Obek; Ali Riza Kural; Dildar Konukoğlu; Tülay Akçay
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

8.  Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate.

Authors:  J E Elkahwaji; R J Hauke; C M Brawner
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

Review 9.  Human benign prostatic hyperplasia heterotransplants as an experimental model.

Authors:  Lluis-A Lopez-Barcons
Journal:  Asian J Androl       Date:  2009-11-30       Impact factor: 3.285

10.  Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.

Authors:  Masashi Nakayama; Christina J Bennett; Jessica L Hicks; Jonathan I Epstein; Elizabeth A Platz; William G Nelson; Angelo M De Marzo
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.